Coeptis Therapeutics Hldgs Inc (COEP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 6,539 | 3,099 | 5,569 | 9,813 | 15,715 |
| Operating Income | -6,539 | -3,099 | -5,569 | -9,813 | -15,715 |
| Interest Expense | 31 | 163 | 56 | 64 | 56 |
| Other Income | -1,387 | 319 | -24 | 74 | -3,409 |
| Pre-tax Income | -7,958 | -2,943 | -5,649 | -9,803 | -19,180 |
| Net Income Continuous | -7,958 | -2,943 | -5,649 | -9,803 | -19,180 |
| Net Income | $-7,958 | $-2,943 | $-5,649 | $-9,803 | $-19,180 |
| EPS Basic Total Ops | -8.00 | 1.20 | -8.40 | -15.00 | -30.40 |
| EPS Basic Continuous Ops | -7.92 | 1.32 | -8.40 | -15.06 | -30.43 |
| EPS Diluted Total Ops | -8.00 | 1.20 | -8.40 | -15.00 | -30.40 |
| EPS Diluted Continuous Ops | -7.92 | 1.32 | -8.40 | -15.06 | -30.43 |
| EBITDA(a) | $-6,289 | $-2,849 | $-5,262 | $-9,499 | $-15,465 |